A Novel SERCA Inhibitor Demonstrates Synergy with Classic SERCA Inhibitors and Targets Multidrug-Resistant AML-Reference-Cited by-同舟云学术

A Novel SERCA Inhibitor Demonstrates Synergy with Classic SERCA Inhibitors and Targets Multidrug-Resistant AML

Published:2013-09-30 Issue:11 Volume:10 Page:4358-4366
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Bleeker Nicholas P.¹,Cornea Razvan L.²,Thomas David D.²,Xing Chengguo¹

Affiliation:

1. Department of Medicinal Chemistry, University of Minnesota, 2231 Sixth St. SE, Minneapolis, Minnesota 55455, United States

2. Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St. SE, Minneapolis, Minnesota 55455, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp400458u

Reference43 articles.

1. Strategies for reversing drug resistance

2. Targeting multidrug resistance in cancer

3. Promoting apoptosis as a strategy for cancer drug discovery

4. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]

5. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel machine learning-based screening identifies statins as inhibitors of the calcium pump SERCA;Journal of Biological Chemistry;2023-05

2. Calcium signaling: A therapeutic target to overcome resistance to therapies in cancer;Cell Calcium;2022-12

3. Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential;Frontiers in Oncology;2022-10-18

4. Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma;International Journal of Molecular Sciences;2022-07-19

5. The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia;IUBMB Life;2022-07-18